78 related articles for article (PubMed ID: 2693110)
1. Infections in compromised hosts: considerations on prevention.
Klastersky J
Eur J Cancer Clin Oncol; 1989; 25 Suppl 2():S53-61. PubMed ID: 2693110
[TBL] [Abstract][Full Text] [Related]
2. Nosocomial infections due to gram-negative bacilli in compromised hosts: considerations for prevention and therapy.
Klastersky J
Rev Infect Dis; 1985; 7 Suppl 4():S552-8. PubMed ID: 3909312
[TBL] [Abstract][Full Text] [Related]
3. Prophylaxis of infection in bone marrow transplants.
Winston DJ; Ho WG; Gale RP; Champlin RE
Eur J Cancer Clin Oncol; 1988; 24 Suppl 1():S15-23. PubMed ID: 3127217
[TBL] [Abstract][Full Text] [Related]
4. Infection and transfusion therapy in acute leukaemia.
Ho WG; Winston DJ
Clin Haematol; 1986 Aug; 15(3):873-904. PubMed ID: 3096621
[TBL] [Abstract][Full Text] [Related]
5. Prophylaxis and treatment of infection in the bone marrow transplant recipient.
Winston DJ
Curr Clin Top Infect Dis; 1993; 13():293-321. PubMed ID: 8397916
[TBL] [Abstract][Full Text] [Related]
6. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
7. Combined antiviral and immunoglobulin therapy as prophylaxis against cytomegalovirus infection after heart transplantation.
Valenza M; Czer LS; Pan SH; Aleksic I; Freimark D; Harasty DA; Admon D; Barath P; Blanche C; Trento A
J Heart Lung Transplant; 1995; 14(4):659-65. PubMed ID: 7578172
[TBL] [Abstract][Full Text] [Related]
8. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
[TBL] [Abstract][Full Text] [Related]
9. Herpesvirus infections (cytomegalovirus, herpes simplex virus, varicella-zoster virus). How to use ganciclovir (DHPG) and acyclovir.
Drew WL; Buhles W; Erlich KS
Infect Dis Clin North Am; 1988 Jun; 2(2):495-509. PubMed ID: 2849621
[TBL] [Abstract][Full Text] [Related]
10. [Characteristics of war wound infection].
Kucisec-Tepes N; Bejuk D; Kosuta D
Acta Med Croatica; 2006 Sep; 60(4):353-63. PubMed ID: 17048790
[TBL] [Abstract][Full Text] [Related]
11. Nosocomial gram-negative bacillary infections in compromised hosts: considerations on prevention and therapy.
Klastersky J
Br J Clin Pract Suppl; 1988 Feb; 57():3-10. PubMed ID: 3140872
[No Abstract] [Full Text] [Related]
12. [Prophylaxis against mycoses in neutropenic patients].
Arning M; Aul C
Mycoses; 1994; 37 Suppl 2():70-6. PubMed ID: 7541892
[TBL] [Abstract][Full Text] [Related]
13. [The essence of infection by opportunistic microorganisms].
Zaremba ML
Przegl Epidemiol; 2001; 55 Suppl 3():91-9. PubMed ID: 11984968
[TBL] [Abstract][Full Text] [Related]
14. Infections in immunocompromised patients. I. Pathogenesis, etiology, and diagnosis.
Klastersky J
Clin Ther; 1985; 8(1):90-9. PubMed ID: 3914372
[TBL] [Abstract][Full Text] [Related]
15. Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients.
Dykewicz CA; ; ;
Clin Infect Dis; 2001 Jul; 33(2):139-44. PubMed ID: 11418871
[TBL] [Abstract][Full Text] [Related]
16. Management of mucocutaneous herpes simplex virus infections in immunocompromised patients.
Saral R
Am J Med; 1988 Aug; 85(2A):57-60. PubMed ID: 3044094
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology and outcomes of multiple antibiotic-resistant bacterial infection in renal transplantation.
Linares L; Cervera C; Cofán F; Ricart MJ; Esforzado N; Torregrosa V; Oppenheimer F; Campistol JM; Marco F; Moreno A
Transplant Proc; 2007 Sep; 39(7):2222-4. PubMed ID: 17889144
[TBL] [Abstract][Full Text] [Related]
18. [Prevention of herpes simplex and varicella zoster infections in patients of HIV infections].
Caumes E; Bricaire F
Ann Med Interne (Paris); 1997; 148(3):255-7. PubMed ID: 9255335
[TBL] [Abstract][Full Text] [Related]
19. [Use of antibiotics for the prevention of bacterial pneumonia in surgical intensive care units].
Baumgartner JD; Glauser MP
Schweiz Med Wochenschr; 1987 May; 117(19):707-11. PubMed ID: 3589627
[TBL] [Abstract][Full Text] [Related]
20. Microbiologic consequences of new approaches to managing hematologic malignancies.
Blijlevens NM; Donnelly JP; de Pauw BE
Rev Clin Exp Hematol; 2005 Dec; 9(2):E2. PubMed ID: 16864116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
